Single vaccine could protect against all coughs, colds and flus, researchers say

A Stanford University team have tested their nasal spray vaccine in animals but still need to do human clinical trials.

Stanford University researchers are developing a single nasal spray that could protect against a vast array of respiratory illnesses, including common colds and flu, with early animal studies showing promising results.

Scientists at Stanford Medicine have developed a universal vaccine formula, tested on mice, that offers broad protection against various respiratory threats and could replace multiple annual jabs.

Researchers at Stanford University have developed a nasal spray vaccine that has shown promise in animal trials for protecting against various respiratory illnesses, including coughs, colds, and flus. Human clinical trials are forthcoming.

Experts at Stanford Medicine in the US have developed a universal vaccine that could be given as a nasal spray and could protect against a wide range of respiratory viruses, bacteria, and allergy triggers. Although the study, published in the journal Science, was in mice, they said the vaccine offered broad protection in the lungs for several months.

Stanford Medicine researchers have developed an intranasal vaccine that protects mice against respiratory viruses, bacteria, and allergens, potentially replacing multiple annual jabs.

A Stanford University team has tested a nasal spray vaccine in animals that could protect against various respiratory illnesses, but human clinical trials are still needed.

Scientists at Stanford Medicine have developed a universal vaccine formula, tested on mice, that offers broad protection against various respiratory threats. The vaccine, delivered as a nasal spray, could protect against cold, flu, Covid, allergies, respiratory viruses, sepsis-causing bacteria, and even house dust mites.